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Delays in tissue fixation following tumour vascular clamping and extirpation may adversely affect subsequent protein and mRNA
analysis. This study investigated the effect of surgically induced ischaemia in a xenograft model of a colorectal cancer on the
expression of a range of prognostic, predictive, and hypoxic markers, with a particular emphasis on thymidylate synthase. Vascular
occlusion of human tumour xenografts by D-shaped metal clamps permitted defined periods of tumour ischaemia. Alterations in
protein expression were measured by immunohistochemistry and spectral imaging, and changes in mRNA were measured by reverse
transcriptase–polymerase chain reaction. Thymidylate synthase expression decreased following vascular occlusion, and this
correlated with cyclin A expression. A similar reduction in dihydropyrimidine dehydrogenase was also seen. There were significant
changes in the expression of several hypoxic markers, with carbonic anhydrase-9 showing the greatest response. Gene transcriptional
levels were also noted to change following tumour clamping. In this xenograft model, surgically induced tumour ischaemia
considerably altered the gene expression profiles of several prognostic and hypoxic markers, suggesting that the degree of tumour
ischaemia should be minimised prior to tissue fixation.
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During the surgical resection of a solid tumour, the principal
arterial supply is clamped in order to obtain vascular control and
thereby facilitate the subsequent dissection and tumour removal.
This vascular clamping and extirpation renders the tumour
ischaemic, during which time tissue proteins undergo proteolytic
degradation until fixed in formalin or liquid nitrogen. Delays in
fixation reduce the efficacy of subsequent protein and mRNA
analysis (Werner et al, 2000; Almeida et al, 2004), and it has
been suggested that tissue fixation should occur within 30min
of surgical extirpation (Werner et al, 2000). However, there are
no formal clinical guidelines regarding the rapidity of fixation,
hence the ischaemic insult may be prolonged unduly.
Hypoxia and acidosis, both of which occur during tumour
vascular clamping (Parkins et al, 1997), are potent mediators of
gene expression (Helfman and Falanga, 1993). Warm ischaemia
following extirpation alters the gene expression profile of a range
of tissue types (Miyatake et al, 2004), and changes in gene
expression have been seen in colorectal mucosa commencing
20min after extirpation (Huang et al, 2001). It was hypothesized,
therefore, that in addition to the effect of degradation following
excision, surgically induced ischaemia occurring during colorectal
cancer (CRC) surgery may have a significant impact on gene
expression levels, thereby altering the expression profiles of
postoperative tumour samples compared with in situ levels.
A range of biomarkers have been investigated as estimates of
prognosis and response to chemotherapy in a number of tumour
types. Thymidylate synthase (TS) has been the most extensively
studied prognostic and predictive marker in CRC (Adlard et al,
2002). It catalyses the reaction that provides the thymidine
nucleotide needed for DNA synthesis, and is the main site of
action of 5-fluorouracil (5-FU) (van der Wilt and Peters, 1994).
High tumour TS levels have been consistently associated with a
poor prognosis (Edler et al, 2000; Takenoue et al, 2000), whereas
low TS levels favour a better outcome to 5-FU-based chemotherapy
(Okonkwo et al, 2001; Aschele et al, 2002). However, studies
investigating TS have shown methodological discrepancies, with
levels being measured in preoperative biopsies and postoperative
archival tumour sections (Edler et al, 2000; Okonkwo et al, 2001).
If surgery alters biomarker levels, this would have major
implications on the timing of marker measurement in relation
to the surgical procedure. Hence, the aim of this study was to
investigate the effect of surgically induced ischaemia on marker
levels in a xenograft model of CRC, looking in particular at TS.
MATERIALS AND METHODS
Subcutaneous tumours were generated by injecting human
HT-29 cells in the dorsal flank of 55 female severe combined
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simmunodeficiency (SCID) mice, and allowed to grow to a diameter
of 0.5cm (approximately 3 weeks). D-shaped metal clamps, which
have been shown to occlude 99.9% of the vascular inflow
(Denekamp et al, 1983), were used to induce vascular occlusion
in the subcutaneous tumours for time periods of 0, 1, 2, 4, 8, 12,
16, 20, and 24h (Figure 1). Five mice were randomly allocated to
each time period. Time point zero (no clamping) was used as an
internal control. All experimental work was carried out in
accordance with Home Office guidelines.
Immunohistochemistry
Table 1 shows the proteins and the conditions used for
immunohistochemistry. Sections (4mm) were dewaxed in xylene
for 5min and rehydrated through graded alcohol (100, 90, and
70%) to water. Heat-mediated antigen retrieval was performed
using 250ml 10mM citric acid, pH 6, for all markers, apart from
vascular endothelial growth factor (VEGF) (0.1 M Tris-HCL pH10)
and carbonic anhydrase-9 (CA-9) (no pretreatment), by boiling the
sections in an 800W microwave oven (Panasonic NN-6453BBPQ,
2450MHz).
For all markers apart from CA-9 and hypoxia-inducible factor-1
(HIF-1)a, sections were transferred to the DAKO Autostaining
machine (DAKO, UK) containing peroxidase block (DAKO,
S2023), the detection reagents (ChemMate HRP, DAKO K5001),
and anti-human primary antibody diluted in antibody diluent. The
Autostainer programme included 5min in peroxidase block, 1h
incubation in primary antibody, 30min incubation in ChemMate
secondary and tertiary reagents, and 5min in diaminobenzidine
(DAB) substrate. An additional step was then performed to mask
the xenograft epitopes and reduce background staining. This was
achieved with Ultravision Rodent Block (Lab Vision Corporation,
Fremont, USA).
Sections were stained for HIF-1a using the DakoCytomation
CSA II signal amplification system (DAKO Corporation, Carpinteria,
USA). In summary, the sections were first incubated with 3%
hydrogen peroxide for 5min to quench endogenous peroxidase
activity, following which incubation with a protein block for 5min
was performed to inhibit nonspecific binding. Diluted primary
antibody was added and sections were incubated for 15min.
Sequential 15min incubations were performed with anti-mouse Ig-
HRP, fluorescyl-tyramide hydrogen peroxide, and anti-fluorescein-
HRP. Finally, the slides were incubated for 5min with DAB/
hydrogen peroxide. For CA-9, endogenous peroxidase activity was
blocked using DAKO peroxidase block (Envision kit) for 5min.
Then, a DAKO Protein Block (X0909) was added for a further
5min, following which incubation with the CA-9 primary antibody
diluted 1/50 in tris-buffered saline (TBS) for 30mins was
performed . A further incubation was then performed with DAKO
Envision HRP Mouse polymer (K4006) for 30min, followed by
5min with DAB solution.
Each staining run incorporated a control slide that had
previously demonstrated positive for the antibody of interest. A
negative control was also incorporated and involved the substitu-
tion of the anti-human primary antibody for an isotypic control
antibody at the same protein concentration.
Quantification of marker protein expression by spectral
imaging
Immunohistochemical staining of marker protein expression was
quantified using a spectral imager developed and constructed in
our Institute, as reported previously (Barber et al, 2003). This
allowed accurate immunostain quantification, with stain intensity
being expressed as optical density (OD) normalized to reference
spectra. Most markers demonstrated greater expression in tumour
cells compared with stroma and by applying arbitrary thresholds
to the OD data, nonspecific background staining could be
minimized on the basis of its lower OD, thus providing exclusive
quantification of marker protein expression within tumour tissue.
For markers exhibiting similar tumour and stromal staining, a
threshold was chosen that included the staining of both tissue
compartments; however, the same threshold was applied to all
images for each marker, thereby minimizing the error of
background staining. In addition, the number of pixels with stain
intensity above the threshold was determined and represented the
area of the captured image demonstrating marker expression. Each
captured image had a high tumour/stroma ratio, hence the total
tumour area was uniform between captured images and allowed
comparison of positively stained area.
Three images were captured using spectral imaging for each
tumour at each time point. Mean stain intensity and area were
determined for each captured image, giving 15 values for each time
point. The data were normalized by taking the ratio of the mean
at the observation time relative to that at time zero. For cyclin A,
images were captured in a similar way; however, a labelling index Figure 1 D-clamps used to occlude tumour vascular inflow.
Table 1 Markers studied, and conditions for immunohistochemistry
Antibody Pretreatment Dilution Source of antibody
Thymidylate synthase (TS) 4 4min microwave in citric acid with 10min standing 1/300 Simon Joel, London, UK
Cyclin A 3 4min microwave in citric acid with 10min standing 1/100 #NCL-CYCLIN A, Novocastra Labs Ltd, UK
Dihydropyrimidine dehydrogenase (DPD) 4 4min microwave in citric acid with 20min standing 1/500 Masakazu Fukushima, Saitama, Japan
Epidermal growth factor receptor (EGFR) 4 4min microwave in citric acid with 20min standing 1/20 #NCL-L-EGFR, Novocastra Labs Ltd, UK
Carbonic anhydrase-9 (CA-9) None 1/50 Adrian Harris, Oxford, UK
Glucose transporter-1 (GLUT-1) 3 4min microwave in citric acid with 10min standing I/200 #A3536, DAKO Corporation, USA
Hypoxia inducible factor-1a (HIF-1a)4  4min microwave in citric acid with 20min standing 1/1000 #ab463-100, Abcam Ltd, UK
Vascular endothelial growth factor (VEGF) 3 4min microwave in Tris-HCL with 10min standing 1/100 #MS-350-P1, NeoMarkers Inc., USA
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s(defined as the ratio of positive to negative nuclei) was manually
calculated for each section and a mean at each duration of
ischaemia was expressed relative to time point zero. Hypoxia-
inducible factor-1 (HIF-1)a expression, which showed mixed
nuclear and cytoplasmic staining, was determined by spectral
imaging and labelling index calculation.
In order to assess the overall trend in expression for each
marker, the area under the curve (AUC) was calculated for the
intensity and area expression profiles of each marker. The change
in expression relative to the basal level was determined by
subtracting 24 (the AUC if there was no change in expression)
from the marker AUC calculation.
Reverse transcriptase–polymerase chain reaction
(RT–PCR)
Tumour samples were removed from frozen storage ( 701C) and
transferred on ice. Total RNA isolation was performed using the
RNeasy
s Mini Kit (Qiagen Ltd, UK). Thymidylate synthase and
HIF-1a RT–PCR was performed using the Platinum
s Quantitative
RT–PCR Thermoscriptt One-Step System (Invitrogent Ltd,
Paisley, UK). b-Actin (bA) was used as an internal control. The
RT–PCR conditions were as follows: 75ng of tumour RNA was
used for each reaction in a final volume of 50ml, containing
150pmol of each TS primer and 75pmol for each set of HIF-1a and
bA primers, 25ml2  Thermoscriptt Reaction buffer, and 1mlo f
Thermoscriptt Plus/Platinum
s Taq Mix. The sequences of the
oligonucleotide primers have been reported previously for TS
(Leichman et al, 1997), HIF-1a (Kuwai et al, 2003), and bA
(Leichman et al, 1997). The following amplification protocol was
used: cDNA synthesis at 601C for 30min, denaturation at 951C for
5min, followed by 28 cycles (for TS and BA) or 25 cycles (for HIF-
1a)o f9 5 1C for 20s, 561C for 30s, and 701C for 30s. Finally, the
PCR products were elongated at 701C for 2min.
The reaction mixtures were subsequently applied to a 1.8%
agarose gel and the amplified products were stained with ethidium
bromide. Following electrophoresis, band intensity was measured
by ultraviolet (UV) densitometry using a custom-built image
capture system consisting of an eight-bit charge-coupled device
(CCD) camera (COHU, Brian Reece Scientific, UK), image capture
board (Data Translations, Basingstoke, UK) DT55–50Hz, eight-bit
786 512 pixels image capture), and an in-house developed
analysis package (based on Visilog software, Datacell, UK).
Thymidylate synthase and HIF-1a mRNA expression were
measured with reference to the housekeeping gene bA. The
TS:b-actin and HIF-1a:bA electrophoresis band intensity ratios
were calculated for each tumour, and the mean ratio at each time
point was expressed relative to time point zero.
Statistics
Spearman’s rank correlation coefficient (rs) was used to determine
the correlation between marker expressions; the statistical
significance was the two-tailed P-value for rejecting the hypothesis
of zero correlation. Differences in marker expression during
clamping were assessed using the Student’s t-test.
RESULTS
Expression profiles of the hypoxic markers
For clarity, the expression of each protein during clamping was
normalized to the time zero value as the OD varied considerably
between the different markers. However, statistical significance
was assessed on the mean OD values obtained from each of the
15 images from each time point. Figure 2A and B show that both
HIF-1a stain intensity and area reduced during the first hour of
ischaemia relative to the basal expression, and then remained at
this level thereafter; all observations were significantly different
to the preclamping value. The HIF-1a nuclear expression profile
was similar to the cytoplasmic profile, but the reduction was more
pronounced. Carbonic anhydrase-9 stain intensity gradually
increased with prolonged ischaemia and became significantly
greater than the preclamping level at 4h (P¼0.002). It reached a
peak 1.8-fold increase at 16h, before reducing to a level not
significantly different to control levels at 24h. The stain area
increased four-fold after only 2h of vascular occlusion (Po0.001),
and remained significantly high thereafter. There was an early
response in glucose transporter-1 (GLUT-1) stain intensity, with
a maximum 1.4-fold increase after 2h of ischaemia (Po0.001),
which remained elevated until 20h before decreasing towards
control levels. There was a similar pattern for the area of tumour-
expressing GLUT-1, which increased after 2h (Po0.001) before
returning to basal levels. Overall, clamping appeared to have little
effect on VEGF stain intensity in this model, with a maximum 1.1-
fold increase occurring at 8h (P¼0.03). Interestingly, VEGF stain
area was significantly reduced throughout the experiment
(Po0.001), apart from a spike occurring at 8h.
Expression profiles of the prognostic markers
The prognostic marker data were analysed in a similar manner to
the hypoxia-related proteins. Figures 3A and B show that the stain
intensity for TS decreased rapidly after the first hour of ischaemia
(Po0.001), and remained significantly lowered throughout the
time course. The effect on area of tumour demonstrating TS
expression was similar, becoming significantly low after 4h
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Figure 2 Stain intensity (A) and area (B) profiles for hypoxic markers.
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s(Po0.001). The expression profile for cyclin A followed that for
TS, reducing throughout the experiment, and becoming signifi-
cantly low after 4h (P¼0.03). Dihydropyrimidine dehydrogenase
stain intensity and area both decreased following clamping
(Po0.01) and remained low throughout. EGFR stain intensity
was unchanged; however, the stain area reduced significantly
during the first hour of hypoxia (Po0.001), and remained low
thereafter, apart from a solitary spike at 8h.
Global changes in marker expression
Figure 4 illustrates the overall pattern of gene expression changes
using area under the curve analysis. Carbonic anhydrase-9,
GLUT-1, and VEGF all show variable increases in stain intensity
secondary to vascular clamping, with CA-9 showing the greatest
increase. The expression of the remaining markers all decreased,
with HIF-1a nuclear staining showing the greatest reduction. For
stain area, only CA-9 and GLUT-1 increased following vascular
occlusion. The remaining markers all decreased, with EGFR having
the greatest reduction.
Changes in protein expression during the likely period of
clinical ischaemia
The changes in expression occurring during the first 4h are the
most likely to be encountered in clinical practice. From Figures 2
and 3, it can be seen that CA-9 and GLUT-1 demonstrated
increases of 40 and 35%, respectively, in stain intensity at 4h,
whereas TS and the nuclear HIF-1a count were reduced by 43
and 90%, respectively. For stain area, there was a 3.7-fold increase
for CA-9, and decreases of 83 and 97% for VEGF and EGFR,
respectively.
Changes in mRNA expression for TS and HIF-1a
It can be seen that the transcriptional profile for TS follows closely
that of the translational response (Figure 5A and B), in that there is
a sustained reduction in expression beginning after the first hour.
HIF-1a mRNA expression was seen to reduce more rapidly than TS
during the initial phase, before returning towards the basal levels
after 16h, and then demonstrating low levels of expression again at
24h.
Relationship between TS expression and markers of
proliferation and hypoxia
There was a significant correlation between TS and cyclin A
expression (rs¼0.67, Po0.05), and an inverse relationship
between TS and CA-9 expression (rs¼ 0.73, P¼0.02), suggesting
that changes in TS were related to changes in the proliferation rate,
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sand that greater degrees of ischaemia were associated with greater
downregulation of TS in this model.
DISCUSSION
This study investigated the effect of surgically induced ischaemia
on CRC gene expression. In this xenograft model, vascular
clamping significantly altered the gene expression profiles of a
number of markers suggested to be indicators of prognosis and
response to chemotherapy. The model mimics in vivo tumour
conditions closely, when tissues may be ischaemic for several
hours following arterial clamping and before fixation. In fact, the
temperature in these subcutaneous tumours approaches ambient
within 1h of clamping, with a protective effect on cell survival
(Chaplin and Horsman, 1994). In vivo tumours will be at body
temperature following clamping until they are removed from the
body. Only then will the temperature approach ambient. There
may be a much greater impact, therefore, on cellular processes,
including gene expression, with in vivo warm ischaemia. Previous
human studies have demonstrated temporal changes in mRNA
expression for multiple genes within a microarray following
extirpation of colonic mucosa, reportedly starting after 20min
(Huang et al, 2001). However, this was not confirmed by Sadahiro
et al (2003) at the protein level, who found no difference in DPD
activity at any time point following excision of colorectal tumour
samples.
To investigate the degree of tumour hypoxia following vascular
clamping, we measured the expression profiles of several
endogenous hypoxia-related markers. Hypoxia-inducible factor-1
is a transcription factor involved in oxygen homeostasis (Zhong
et al, 1999). The action of HIF-1 is to stimulate genes whose
protein products act to increase oxygen availability or adapt to
oxygen deprivation. These genes include erythropoietin, VEGF,
GLUT-1, and CA-9 (Gillies et al, 2002). In vitro experiments have
shown that HIF-1a increases rapidly within 30min of a hypoxic
stimulus, peaking at 2–4h (Wiesener et al, 1998). However, we did
not see an increase in HIF-1a expression in this model. This may
be related to HIF-1a regulation by hypoxia-independent mecha-
nisms (Kunz and Ibrahim, 2003) and/or greater HIF-1 degradation
in totally anoxic tumours. In this xenograft model, tumours were
exposed to chronic, or diffusion-limited, hypoxia, which HIF-1a
reflects poorly (Janssen et al, 2002).
Hypoxia has been shown to induce CA-9 protein in vitro
(Wykoff et al, 2000), and CA-9 has been shown to correlate with
hypoxia measured by Eppendorf histography in carcinoma of the
cervix (Loncaster et al, 2001). In our model, CA-9 expression
showed the greatest increase for any marker, with a peak occurring
after 16h. CA-9 represents the response of tumours to chronic
hypoxia (Hui et al, 2002), and our findings are in agreement with
Lal et al (2001) who found CA-9 transcripts increased after 12h of
hypoxia in glioblastoma cells. Both GLUT-1 and VEGF have been
shown to be upregulated in hypoxic conditions (Bashan et al, 1992;
Paulding and Czyzyk-Krzeska, 2000). We found there was an early
increase in GLUT-1 protein expression in response to surgically
induced ischaemia; however, we did not see much variation in
VEGF stain intensity. This is similar to Lal et al (2001) who found
VEGF had one of the smallest in vitro hypoxic responses of a range
of genes studied. The different expression profiles of the hypoxic
markers studied in our model could be explained by their different
susceptibilities to low oxygen and the rapidity of their response.
In addition, the degree of necrosis in our experimental tumours
following clamping is unknown, and the level of protein expression
at any duration of ischaemia may represent the balance between
hypoxic gene induction and protein degradation.
Previous experimental models of arterial occlusion have
confirmed that changes in protein and mRNA expression do
occur after variable periods of ischaemia. Rat testicular artery
ligation for up to 6h did not alter HIF-1 mRNA expression, but did
lead to a two-fold increase in testicular HIF-1 protein expression
after only 30min (Powell et al, 2002); whereas rat middle cerebral
artery occlusion led to an increase in HIF-1a and GLUT-1 mRNA
in the ischaemic penumbra after 7.5h (Bergeron et al, 1999). It
may be that in vivo tissue ischaemia following vascular occlusion
involves distinct responses to hypoxia and cellular energy
depletion. A 45min of rat renal ischaemia induced by vascular
clamping was associated with increased HIF-1 and heat shock
factor-1 (HSF-1) levels, whereas in vitro ATP depletion increased
HSF-1 levels in isolation and hypoxia led to increased HIF-1
expression alone (Eickelberg et al, 2002).
The most widely studied prognostic and predictive marker in
CRC is TS. We found surgically induced ischaemia had a
pronounced effect on TS stain intensity, with a marked reduction
in expression throughout the duration of ischaemia. Thymidylate
synthase expression correlated with cylin A expression, suggesting
that changes in TS were related to changes in the proliferation rate.
Hypoxia slows the metabolic rate and is associated with lower
levels of transcription and translation (Dachs and Tozer, 2000).
Also, cell cycle arrest has been shown to be due to the hypoxic
inactivation of nucleotide synthesis enzymes (Lando et al, 2002).
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Figure 5 mRNA expression profiles for TS and HIF-1a (A) and the
global changes in their expression (B).
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model represent the changes in the cell proliferation rate
secondary to hypoxia. Indeed, TS has been suggested to be a
marker of proliferation (Derenzini et al, 2002), and in vivo studies
have found a significant correlation with the expression of the
proliferation marker Ki-67 in rectal cancer (Edler et al, 2002). We
noted TS expression was related to the duration of ischaemia, and
correlated inversely with CA-9 expression. It may be that the
greater TS downregulation seen at these lower oxygen levels relates
to the reduced cell turnover at this degree of hypoxia. Few studies
have investigated the hypoxic response of the TS gene. An in vitro
breast cancer study did report a reduced expression secondary to
low oxygen tensions (Ehrnrooth et al, 1999); however, there was no
correlation between TS expression and tumour hypoxia measured
by Eppendorf histography in rectal cancer patients (Mattern et al,
1996).
The changes in TS and HIF-1a transcription were similar to their
translational response, with a reduced mRNA expression following
vascular clamping. Unlike the protein response, hypoxia has been
shown to have little effect on HIF-1a transcription in cell culture
(Giaccia et al, 2003). Similarly, TS is mainly controlled at the
translational level (Liu et al, 2002), which provides an energy-
efficient, rapid response to cellular stresses. However, we noted a
sustained effect of ischaemia on TS and HIF-1a mRNA levels,
highlighting the need for rapid preservation following tissue
extirpation.
Dihydropyrimidine dehydrogenase is another putative prognos-
tic marker in CRC. It is involved in the breakdown of uracil and
thymine and is also the first, rate-limiting step in 5-FU catabolism
(Beck et al, 1994). We found vascular clamping had a significant
effect on both DPD stain intensity and area. Previous studies have
found no correlation between DPD activity and time following
extirpation of CRC samples (Sadahiro et al, 2003). Epidermal
growth factor receptor is a member of the tyrosine kinase family of
receptors and mediates the actions of several growth factors. It is
frequently overexpressed in malignant tissues, and has been shown
to be induced by hypoxia in a number of tumour types (Nishi et al,
2002; Gunaratnam et al, 2003). However, we did not see any effect
of clamping on EGFR stain intensity, but there was an early
decrease in stained area. As growth factor receptors are involved
in cell division (Wahl and Carpenter, 1987), it may be the reduced
expression seen that reflects the inhibition of cell proliferation
occurring following tumour clamping.
The duration of tumour ischaemia most likely encountered in
clinical practice would be up to 4h. During this period, the arterial
supply would be interrupted, the tumour would be resected, and
the specimen fixed in formalin. Our data suggest that changes in
gene expression do occur during this time frame. In particular, the
expression of TS, CA-9, GLUT-1, and HIF-1a were all seen to alter
considerably after 4h, and these changes could be clinically
relevant.
In this xenograft model, surgically induced tumour ischaemia
altered the gene expression profiles of several markers purported
to be indicators of prognosis and response to chemotherapy
regimens in CRC, as well as estimates of tissue hypoxia. If these
findings are reproduced in human tumours, they would have
important implications on surgical technique and subsequent
marker measurement. The results suggest that the length and
degree of tumour ischaemia should be minimised prior to tissue
fixation. This may be achieved by delayed vascular clamping or
immediate fixation following extirpation. The findings also suggest
the need for formal guidelines on rapidity of tissue fixation
following surgical excision. Although CRC was the studied model,
the results may be applicable to any tumour undergoing
extirpation in which molecular markers have been proposed to
dictate therapeutic strategy.
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